Should pediatric patients wait for HLA-DR-matched renal transplants?

Am J Transplant. 2008 Oct;8(10):2056-61. doi: 10.1111/j.1600-6143.2008.02320.x.

Abstract

Graft survival rates from deceased donors aged 35 years or less among all primary pediatric kidney transplant recipients in the United States between 1996 and 2004 were retrospectively examined to determine the effect of HLA-DR mismatches on graft survival. Zero HLA-DR-mismatched kidneys had statistically comparable 5-year graft survival (71%), to 1-DR-mismatched kidneys (69%) and 2-DR-mismatched kidneys (71%). When compared to donors less than 35 years of age, the relative rate of allograft failure was 1.32 (p = 0.0326) for donor age greater than or equal to age 35. There was no statistical increase in the odds of developing a panel-reactive antibody (PRA) greater than 30% at the time of second waitlisting, based upon the degree of HLA-A, -B or -DR mismatch of the first transplant, nor was there a 'dose effect' when more HLA antigens were mismatched between the donor and recipient. Therefore, pediatric transplant programs should utilize the recently implemented Organ Procurement and Transplantation Network's (OPTN)allocation policy, which prioritizes pediatric recipients to receive kidneys from deceased donors less than 35 years of age, and should not turn down such kidney offers to wait for a better HLA-DR-matched kidney.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Child
  • Child, Preschool
  • Graft Survival
  • HLA-DR Antigens / biosynthesis*
  • Histocompatibility Testing
  • Humans
  • Infant
  • Infant, Newborn
  • Kidney / pathology
  • Kidney Diseases / mortality
  • Kidney Diseases / therapy*
  • Kidney Transplantation / methods*
  • Middle Aged
  • Tissue Donors
  • Tissue and Organ Procurement*

Substances

  • HLA-DR Antigens